Beth Wilmot Selected Research

Precision Medicine

1/2016

Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beth Wilmot Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 10/2011
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2015
5	Leukemia 01/2020 - 05/2013
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 06/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 10/2011
1	Vascular Diseases (Vascular Disease) 01/2021
1	Genetic Risk Score 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019
1	Ocular Toxoplasmosis 01/2019
1	Infections 01/2019
1	Juvenile Myelomonocytic Leukemia 01/2018
1	Hypernatremia 08/2017
1	Chronic Neutrophilic Leukemia 01/2017
1	Neutropenia 01/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2015
1	Otitis Media 01/2015
1	Otitis Media with Effusion 05/2014
1	Type V Osteogenesis Imperfecta 12/2013
1	Kidney Diseases (Kidney Disease) 02/2012
1	Dental Caries (Decay, Dental) 01/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2010
1	Hyponatremia 08/2009
1	Cognitive Dysfunction 04/2008
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 07/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2006
1	Parkinson Disease (Parkinson's Disease) 07/2006
1	Karak Syndrome 07/2006
1	Neurodegeneration with brain iron accumulation (NBIA) 07/2006
1	Alzheimer Disease (Alzheimer's Disease) 07/2006

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 01/2022 - 05/2013
4	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 05/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 05/2013
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2011
2	SodiumIBA 02/2012 - 08/2009
1	Aurora Kinase AIBA 11/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Unithiol (DMPS)IBA 01/2020
1	venetoclaxIBA 01/2020
1	crenolanibIBA 01/2019
1	Retinal Pigments (Pigments, Visual)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Protein Tyrosine PhosphatasesIBA 01/2018
1	ElectrolytesIBA 08/2017
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	Fibronectins (Fibronectin)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 12/2015
1	src-Family KinasesIBA 12/2015
1	Dasatinib (BMS 354825)FDA Link 12/2015
1	Anaplastic Lymphoma KinaseIBA 06/2015
1	Toll-Like Receptor 4IBA 01/2015
1	Methionine (L-Methionine)FDA Link 12/2013
1	Initiator Codon (Start Codon)IBA 12/2013
1	NucleotidesIBA 12/2013
1	LigandsIBA 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	FluoridesIBA 01/2012
1	ParaffinIBA 10/2011
1	ChromatinIBA 10/2011
1	A-Form DNA (A-DNA)IBA 10/2011
1	Imatinib Mesylate (Gleevec)FDA Link 01/2010
1	CalciumIBA 07/2006
1	IronIBA 07/2006
1	Phospholipases A2 (Phospholipase A2)IBA 07/2006
1	Group VI Phospholipases A2IBA 07/2006
1	Phospholipases (Phospholipase)IBA 07/2006

Therapy/Procedure

5	Therapeutics 11/2021 - 01/2010
1	Precision Medicine 01/2016
1	Castration 01/2013